Page last updated: 2024-10-19

thioctic acid and Multiple Myeloma

thioctic acid has been researched along with Multiple Myeloma in 1 studies

Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maschio, M1
Zarabla, A1
Maialetti, A1
Marchesi, F1
Giannarelli, D1
Gumenyuk, S1
Pisani, F1
Renzi, D1
Galiè, E1
Mengarelli, A1

Other Studies

1 other study available for thioctic acid and Multiple Myeloma

ArticleYear
Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary Data.
    Integrative cancer therapies, 2018, Volume: 17, Issue:4

    Topics: Aged; Antineoplastic Agents; Bortezomib; Docosahexaenoic Acids; Female; Humans; Male; Middle Aged; M

2018